Markus Dettenkofer1, Hilary Humphreys2,3, Henri Saenz4, Jean Carlet5, Håkan Hanberger6, Christian Ruef7, Andreas Widmer8, Martin Wolkewitz9, Barry Cookson10. 1. Medical Centre, University of Freiburg, Institute for Environmental Health Sciences and Hospital Infection Control, Freiburg, Germany. markus.dettenkofer@glkn.de. 2. Department of Clinical Microbiology, The Royal College of Surgeons, Dublin, Ireland. 3. Department of Microbiology, Beaumont Hospital, Dublin, Ireland. 4. European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Basel, Switzerland. 5. Consultant, Groupe Hospitalier Paris St Joseph, Paris, France. 6. Division of Infectious Diseases, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University and Östergötland County Council, Linköping, Sweden. 7. Division of Infectious Diseases and Hospital Epidemiology, Hirslanden Klinik, Zurich, Switzerland. 8. Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland. 9. Institute of Medical Biometry and Medical Informatics, University of Freiburg, Freiburg, Germany. 10. Division of Infection and Immunity, University College London, Gower Street, London, UK.
Abstract
PURPOSE: Prevention and control of healthcare-associated infection (HCAI) are important within and beyond Europe. However, it is unclear which areas are considered important by HCAI prevention and control professionals. This study assesses the priorities in the prevention and control of HCAI as judged by experts in the field. METHODS: A survey was conducted by the European Society of Clinical Microbiology and Infectious Diseases focussing on seven topics using SurveyMonkey®. Through a newsletter distributed by email, about 5000 individuals were targeted throughout the world in February and March 2013. Participants were asked to rate the importance of particular topics from one (low importance) to ten (extraordinary importance), and there was no restriction on giving equal importance to more than one topic. RESULTS: A total of 589 experts from 86 countries participated including 462 from Europe (response rate: 11.8 %). Physicians accounted for 60 % of participants, and 57 % had ten or more years' experience in this area. Microbial epidemiology/resistance achieved the highest priority scoring with 8.9, followed by surveillance 8.2, and decolonisation/disinfection/antiseptics with 7.9. Under epidemiology/resistance, highly resistant Gram-negative bacilli scored highest (9.0-9.2). The provision of computerised healthcare information systems for the early detection of outbreaks was accorded the top priority under surveillance. The prevention of surgical site and central line infections ranked highest under the category of specific HCAI and HCAI in certain settings. Differences between regions are described. CONCLUSION: These findings reflect the concerns of experts in HCAI prevention and control. The results from this survey should inform national and international agencies on future action and research priorities.
PURPOSE: Prevention and control of healthcare-associated infection (HCAI) are important within and beyond Europe. However, it is unclear which areas are considered important by HCAI prevention and control professionals. This study assesses the priorities in the prevention and control of HCAI as judged by experts in the field. METHODS: A survey was conducted by the European Society of Clinical Microbiology and Infectious Diseases focussing on seven topics using SurveyMonkey®. Through a newsletter distributed by email, about 5000 individuals were targeted throughout the world in February and March 2013. Participants were asked to rate the importance of particular topics from one (low importance) to ten (extraordinary importance), and there was no restriction on giving equal importance to more than one topic. RESULTS: A total of 589 experts from 86 countries participated including 462 from Europe (response rate: 11.8 %). Physicians accounted for 60 % of participants, and 57 % had ten or more years' experience in this area. Microbial epidemiology/resistance achieved the highest priority scoring with 8.9, followed by surveillance 8.2, and decolonisation/disinfection/antiseptics with 7.9. Under epidemiology/resistance, highly resistant Gram-negative bacilli scored highest (9.0-9.2). The provision of computerised healthcare information systems for the early detection of outbreaks was accorded the top priority under surveillance. The prevention of surgical site and central line infections ranked highest under the category of specific HCAI and HCAI in certain settings. Differences between regions are described. CONCLUSION: These findings reflect the concerns of experts in HCAI prevention and control. The results from this survey should inform national and international agencies on future action and research priorities.
Authors: A P Magiorakos; E Leens; V Drouvot; L May-Michelangeli; C Reichardt; P Gastmeier; K Wilson; M Tannahill; E McFarlane; A Simon Journal: Euro Surveill Date: 2010-05-06
Authors: M Dettenkofer; A Ammon; P Astagneau; S J Dancer; P Gastmeier; S Harbarth; H Humphreys; W V Kern; O Lyytikäinen; H Sax; A Voss; A F Widmer Journal: J Hosp Infect Date: 2010-12-09 Impact factor: 3.926
Authors: Susan S Huang; Edward Septimus; Ken Kleinman; Julia Moody; Jason Hickok; Taliser R Avery; Julie Lankiewicz; Adrijana Gombosev; Leah Terpstra; Fallon Hartford; Mary K Hayden; John A Jernigan; Robert A Weinstein; Victoria J Fraser; Katherine Haffenreffer; Eric Cui; Rebecca E Kaganov; Karen Lolans; Jonathan B Perlin; Richard Platt Journal: N Engl J Med Date: 2013-05-29 Impact factor: 91.245
Authors: Lennie P G Derde; Ben S Cooper; Herman Goossens; Surbhi Malhotra-Kumar; Rob J L Willems; Marek Gniadkowski; Waleria Hryniewicz; Joanna Empel; Mirjam J D Dautzenberg; Djillali Annane; Irene Aragão; Annie Chalfine; Uga Dumpis; Francisco Esteves; Helen Giamarellou; Igor Muzlovic; Giuseppe Nardi; George L Petrikkos; Viktorija Tomic; Antonio Torres Martí; Pascal Stammet; Christian Brun-Buisson; Marc J M Bonten Journal: Lancet Infect Dis Date: 2013-10-23 Impact factor: 25.071
Authors: Danielle Vuichard Gysin; Barry Cookson; Henri Saenz; Markus Dettenkofer; Andreas F Widmer Journal: Antimicrob Resist Infect Control Date: 2018-07-09 Impact factor: 4.887